Reports
Reports
Sale
The global dialysis market size attained a value of nearly USD 109.51 billion in 2023. The market is likely to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to attain a value of USD 178.82 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Dialysis is a procedure for people with advanced chronic kidney disease (CKD) or kidney failure. Haemodialysis and peritoneal dialysis are the two types of dialysis that can help in filtering out unwanted fluids and substances from the blood when the kidney of the patient is not working properly. Haemodialysis is the most common form of dialysis in which the blood of the patient is passed through an external dialysis machine and is usually carried out 3 days a week, with each session lasting around 4 hours.
Chronic kidney disease (CKD) results in a progressive loss of kidney function over time. It prompts the patient to undergo dialysis at an advanced stage of the disease if kidney transplantation is not a feasible option. With rise in conditions like diabetes and high blood pressure, the prevalence of CKD is on the rise, posing a greater risk for kidney failure. Approximately 37 million or 1 in 7 Americans have chronic kidney disease, prompting the need for improved and efficient dialysis products and services. Thus, the rising incidence of chronic kidney disease acts as a key driver for dialysis market growth. In addition, technological advancements and the introduction of novel products are also contributing to the increasing market demand.
Surge in Mergers and Acquisition Activities
Increased mergers and acquisitions between healthcare providers have facilitated the diversification of products and services offered in the patient dialysis market. In June 2023, Merit Medical Systems Inc., a leading manufacturer and marketer of medical devices, added USD 132.5 million worth of dialysis and related products in their existing product portfolio. With this acquisition, Merit Medical Systems aimed to expand the portfolio of its specialty dialysis devices to accommodate the rising dialysis market demand. The company purchased medical assets from two medical technology firms based in the United States, Angiodynamics Inc. and Bluegrass Vascular Technologies, for USD 100 million and USD 32.5 million, respectively. Furthermore, it is anticipated that the acquisition initiative will boost the revenue of the firm and solidify its presence in the dialysis devices market.
Increased Fundings to Boost Dialysis Market Share
Significant funding from firms, private investors, government, or non-profit organizations is bolstering the market growth of dialysis devices. In September 2023 , AWAK Technologies headquartered in Singapore, announced that it had raised over USD 20 million in Series B funding. With the help of this funding, the company will complete the ongoing human pre-pivotal clinical trial for its ultraportable peritoneal dialysis (PD) system AWAK PD. In addition, AWAK Technologies plans to develop new products promoting home dialysis and integrated digital solutions to improve the quality of life for chronic kidney disease patients.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Treatment Type
Market Breakup by Product & Service
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America has a large share of the dialysis market which can attributed to factors such as the increasing number of end stage renal disease (ESRD) patients and the rising prevalence of diabetes and hypertension. Another key factor is the rising technological advancements by the prominent healthcare companies in the region, fuelling the market size significantly. In November 2023 , Baxter International Inc., announced the launch of Sharesource, their digital health platform for home dialysis. It can reduce peritoneal dialysis (PD) technique failure by 77% when used with an automated PD system.
Supported by the expansion and development of the healthcare infrastructure, Europe holds a significant dialysis market share. In September 2023 , Fresenius Medical Care (FME) expanded its in-house technical capabilities by opening a new head office in Huthwaite to meet the growing demand for renal therapies. Additionally, the emerging economies from the Asia Pacific region are anticipated to become the main revenue-generating areas due to the rising investment in the healthcare sector and supportive healthcare public operations.
In June 2023, a United States-based manufacturer of hemodialysis products, Rockwell Medical, Inc., announced a co-promotional collaboration with B. Braun Medical for a period of 3 years. As part of the agreement, the national sales force of B. Braun will help in the promotion of hemodialysis concentrate products of Rockwell Medical in the United States region. The collaboration will ensure the supply of a wide range of high-quality hemodialysis products to the growing consumer base.
The key features of the dialysis market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Treatment Type |
|
Breakup by Product & Service |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Dialysis Market (2017-2032) Overview
3.1 Global Dialysis Market (2017-2032) Historical Value (2017-2023)
3.2 Global Dialysis Market (2017-2032) Forecast Value (2024-2032)
4 Global Dialysis Market (2017-2032) Landscape*
4.1 Dialysis: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Dialysis: Product Landscape
4.2.1 Analysis by Treatment Type
4.2.2 Analysis by Product & Service
5 Global Dialysis Market (2017-2032) Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Dialysis Market (2017-2032) Segmentation
6.1 Global Dialysis Market (2017-2032) by Treatment Type
6.1.1 Market Overview
6.1.2 Hemodialysis Dialysis
6.1.3 Peritoneal Dialysis
6.2 Global Dialysis Market (2017-2032) by Product & Service
6.2.1 Market Overview
6.2.2 Equipment
6.2.3 Consumables
6.2.4 Drugs
6.2.5 Services
6.2.6 Other Dialysis Products
6.3 Global Dialysis Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 In-center Dialysis
6.3.3 Home Dialysis
6.3.4 Others
6.4 Global Dialysis Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Dialysis Market (2017-2032)
7.1 North Dialysis Market (2017-2032) by Treatment Type
7.1.1 Market Overview
7.1.2 Hemodialysis Dialysis
7.1.3 Peritoneal Dialysis
7.2 North Dialysis Market (2017-2032) by Product & Service
7.2.1 Market Overview
7.2.2 Equipment
7.2.3 Consumables
7.2.4 Drugs
7.2.5 Services
7.2.6 Other Dialysis Products
7.3 North Dialysis Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Dialysis Market (2017-2032)
8.1 Europe Dialysis Market (2017-2032) by Treatment Type
8.1.1 Market Overview
8.1.2 Hemodialysis Dialysis
8.1.3 Peritoneal Dialysis
8.2 Europe Dialysis Market (2017-2032) by Product & Service
8.2.1 Market Overview
8.2.2 Equipment
8.2.3 Consumables
8.2.4 Drugs
8.2.5 Services
8.2.6 Other Dialysis Products
8.3 Europe Dialysis Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Dialysis Market (2017-2032)
9.1 Asia Pacific Dialysis Market (2017-2032) by Treatment Type
9.1.1 Market Overview
9.1.2 Hemodialysis Dialysis
9.1.3 Peritoneal Dialysis
9.2 Asia Pacific Dialysis Market (2017-2032) by Product & Service
9.2.1 Market Overview
9.2.2 Equipment
9.2.3 Consumables
9.2.4 Drugs
9.2.5 Services
9.2.6 Other Dialysis Products
9.3 Asia Pacific Dialysis Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Dialysis Market (2017-2032)
10.1 Latin Dialysis Market (2017-2032) by Treatment Type
10.1.1 Market Overview
10.1.2 Hemodialysis Dialysis
10.1.3 Peritoneal Dialysis
10.2 Latin Dialysis Market (2017-2032) by Product & Service
10.2.1 Market Overview
10.2.2 Equipment
10.2.3 Consumables
10.2.4 Drugs
10.2.5 Services
10.2.6 Other Dialysis Products
10.3 Latin Dialysis Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Dialysis Market (2017-2032)
11.1 Middle East and Africa Dialysis Market (2017-2032) by Treatment Type
11.1.1 Market Overview
11.1.2 Hemodialysis Dialysis
11.1.3 Peritoneal Dialysis
11.2 Middle East and Africa Dialysis Market (2017-2032) by Product & Service
11.2.1 Market Overview
11.2.2 Equipment
11.2.3 Consumables
11.2.4 Drugs
11.2.5 Services
11.2.6 Other Dialysis Products
11.3 Middle East and Africa Dialysis Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 NIKKISO CO. LTD
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 ASAHI KASEI CORPORATION
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 FRESENIUS SE AND CO
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 DIAVERUM DEUTSCHLAND GmbH
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 B. BRAUN MELSUNGEN AG
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 NIPRO CORPORATION
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 ANGIODYNAMICS INC
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 DAVITA
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 BECTON, DICKINSON AND COMPANY
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 BAXTER INTERNATIONAL INC
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Toray Industries Inc
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Dia life
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 Teleflex Incorporated
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 JMS Co Ltd
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 Medtronic Plc
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Dialysis Market (2017-2032) - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customizable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 109.51 billion in 2023 driven by the rising prevalence of chronic kidney diseases.
The market is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032, likely to reach a market value of USD 178.82 billion by 2032.
Technological advancements and the introduction of novel dialysis products and services are contributing to the increasing the market demand.
The surge in funding and investments is one of the major trends driving the dialysis market. In September 2023, AWAK Technologies announced that it had raised over USD 20 million in Series B funding, to support the clinical trial of its ultraportable peritoneal dialysis (PD) system, AWAK PD.
The market is divided into hemodialysis and peritoneal dialysis based on the treatment types.
The products and services in the market include equipment, consumables, drugs, services, and other dialysis products.
Major end users in the market include in-center and home dialysis, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Nikkiso Co. Ltd, Asahi Kasei Corporation, Fresenius SE and Co, Diaverum Deutschland GmbH, B. Braun Melsungen AG, Nipro Corporation, Angiodynamics Inc, Davita, Becton, Dickinson and Company, Baxter International Inc, Toray Industries Inc, Dia life, Teleflex Incorporated, JMS Co Ltd, and Medtronic Plc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.